+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autoimmune Disease Therapeutics - Market Analysis, Trends, and Forecasts

  • ID: 1056063
  • Report
  • 259 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Abbvie
  • Amgen
  • Astrazeneca Plc
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • MORE
The Autoimmune Disease Therapeutics market worldwide is projected to grow by US$36 Billion, driven by a compounded growth of 4.1%. Anti-inflammatory, one of the segments analyzed and sized in this study, displays the potential to grow at over 4.7%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$79.1 Billion by the year 2025, Anti-inflammatory will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.3 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.1 Billion worth of projected demand in the region will come from the rest of the European markets. In Japan, Anti-inflammatory will reach a market size of US$4.6 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6.4% over the next couple of years and add approximately US$10.2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Abbott Laboratories, Inc.
  • AbbVie, Inc.
  • Amgen, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer, Inc.
  • UCB SA
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Abbvie
  • Amgen
  • Astrazeneca Plc
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • MORE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Autoimmune Disease Therapeutics Competitor Market Share Scenario Worldwide (in %):2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Autoimmune Disease Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Autoimmune Disease Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Autoimmune Disease Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Anti-inflammatory (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Anti-inflammatory (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Anti-inflammatory (Drug Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Antihyperglycemics (Drug Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Antihyperglycemics (Drug Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Antihyperglycemics (Drug Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: NSAIDs (Drug Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: NSAIDs (Drug Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: NSAIDs (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Interferons (Drug Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Interferons (Drug Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Interferons (Drug Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Other Drug Class (Drug Class) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Other Drug Class (Drug Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Other Drug Class (Drug Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Rheumatic Disease (Indication) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025

TABLE 20: Rheumatic Disease (Indication) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 21: Rheumatic Disease (Indication) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Type 1 Diabetes (Indication) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025

TABLE 23: Type 1 Diabetes (Indication) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017

TABLE 24: Type 1 Diabetes (Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Multiple Sclerosis (Indication) World Market by Region/Country in US$ Million:2018 to 2025

TABLE 26: Multiple Sclerosis (Indication) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 27: Multiple Sclerosis (Indication) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 28: Inflammatory Bowel Disease (Indication) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 29: Inflammatory Bowel Disease (Indication) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 30: Inflammatory Bowel Disease (Indication) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 31: Other Indications (Indication) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 32: Other Indications (Indication) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 33: Other Indications (Indication) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Autoimmune Disease Therapeutics Market Share (in %) by Company: 2019 & 2025

TABLE 34: United States Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 35: Autoimmune Disease Therapeutics Market in the United States by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 36: United States Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 37: United States Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Indication: 2018 to 2025

TABLE 38: Autoimmune Disease Therapeutics Market in the United States by Indication: A Historic Review in US$ Million for 2009-2017

TABLE 39: United States Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

CANADA

TABLE 40: Canadian Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 41: Canadian Autoimmune Disease Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 42: Autoimmune Disease Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 43: Canadian Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025

TABLE 44: Canadian Autoimmune Disease Therapeutics Historic Market Review by Indication in US$ Million: 2009-2017

TABLE 45: Autoimmune Disease Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025

JAPAN

TABLE 46: Japanese Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 47: Autoimmune Disease Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 48: Japanese Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 49: Japanese Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025

TABLE 50: Autoimmune Disease Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017

TABLE 51: Japanese Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025

CHINA

TABLE 52: Chinese Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 53: Autoimmune Disease Therapeutics Historic Market Analysis in China in US$ Million by Drug Class: 2009-2017

TABLE 54: Chinese Autoimmune Disease Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 55: Chinese Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Indication for the Period 2018-2025

TABLE 56: Autoimmune Disease Therapeutics Historic Market Analysis in China in US$ Million by Indication: 2009-2017

TABLE 57: Chinese Autoimmune Disease Therapeutics Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Autoimmune Disease Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 58: European Autoimmune Disease Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 59: Autoimmune Disease Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 60: European Autoimmune Disease Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 61: European Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 62: Autoimmune Disease Therapeutics Market in Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 63: European Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 64: European Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018-2025

TABLE 65: Autoimmune Disease Therapeutics Market in Europe in US$ Million by Indication: A Historic Review for the Period 2009-2017

TABLE 66: European Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

FRANCE

TABLE 67: Autoimmune Disease Therapeutics Market in France by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 68: French Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 69: French Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 70: Autoimmune Disease Therapeutics Market in France by Indication: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 71: French Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Indication: 2009-2017

TABLE 72: French Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025

GERMANY

TABLE 73: Autoimmune Disease Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 74: German Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 75: German Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 76: Autoimmune Disease Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025

TABLE 77: German Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017

TABLE 78: German Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

ITALY

TABLE 79: Italian Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 80: Autoimmune Disease Therapeutics Historic Market Analysis in Italy in US$ Million by Drug Class: 2009-2017

TABLE 81: Italian Autoimmune Disease Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 82: Italian Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Indication for the Period 2018-2025

TABLE 83: Autoimmune Disease Therapeutics Historic Market Analysis in Italy in US$ Million by Indication: 2009-2017

TABLE 84: Italian Autoimmune Disease Therapeutics Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 85: United Kingdom Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 86: Autoimmune Disease Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 87: United Kingdom Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 88: United Kingdom Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025

TABLE 89: Autoimmune Disease Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017

TABLE 90: United Kingdom Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025

SPAIN

TABLE 91: Spanish Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 92: Spanish Autoimmune Disease Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 93: Autoimmune Disease Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 94: Spanish Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025

TABLE 95: Spanish Autoimmune Disease Therapeutics Historic Market Review by Indication in US$ Million: 2009-2017

TABLE 96: Autoimmune Disease Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025

RUSSIA

TABLE 97: Russian Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 98: Autoimmune Disease Therapeutics Market in Russia by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 99: Russian Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 100: Russian Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Indication: 2018 to 2025

TABLE 101: Autoimmune Disease Therapeutics Market in Russia by Indication: A Historic Review in US$ Million for 2009-2017

TABLE 102: Russian Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 103: Rest of Europe Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 104: Autoimmune Disease Therapeutics Market in Rest of Europe in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 105: Rest of Europe Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 106: Rest of Europe Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018-2025

TABLE 107: Autoimmune Disease Therapeutics Market in Rest of Europe in US$ Million by Indication: A Historic Review for the Period 2009-2017

TABLE 108: Rest of Europe Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 109: Asia-Pacific Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 110: Autoimmune Disease Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 111: Asia-Pacific Autoimmune Disease Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 112: Autoimmune Disease Therapeutics Market in Asia-Pacific by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 113: Asia-Pacific Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 114: Asia-Pacific Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 115: Autoimmune Disease Therapeutics Market in Asia-Pacific by Indication: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 116: Asia-Pacific Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Indication: 2009-2017

TABLE 117: Asia-Pacific Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 118: Autoimmune Disease Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 119: Australian Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 120: Australian Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 121: Autoimmune Disease Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025

TABLE 122: Australian Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017

TABLE 123: Australian Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

INDIA

TABLE 124: Indian Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 125: Indian Autoimmune Disease Therapeutics Historic Market Review by Drug Class in US$ Million: 2009-2017

TABLE 126: Autoimmune Disease Therapeutics Market in India: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 127: Indian Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025

TABLE 128: Indian Autoimmune Disease Therapeutics Historic Market Review by Indication in US$ Million: 2009-2017

TABLE 129: Autoimmune Disease Therapeutics Market in India: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025

SOUTH KOREA

TABLE 130: Autoimmune Disease Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 131: South Korean Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 132: Autoimmune Disease Therapeutics Market Share Distribution in South Korea by Drug Class: 2009 VS 2019 VS 2025

TABLE 133: Autoimmune Disease Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025

TABLE 134: South Korean Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017

TABLE 135: Autoimmune Disease Therapeutics Market Share Distribution in South Korea by Indication: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 136: Rest of Asia-Pacific Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 137: Autoimmune Disease Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 138: Rest of Asia-Pacific Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 139: Rest of Asia-Pacific Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025

TABLE 140: Autoimmune Disease Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017

TABLE 141: Rest of Asia-Pacific Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 142: Latin American Autoimmune Disease Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 143: Autoimmune Disease Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 144: Latin American Autoimmune Disease Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 145: Latin American Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 146: Autoimmune Disease Therapeutics Historic Market Analysis in Latin America in US$ Million by Drug Class: 2009-2017

TABLE 147: Latin American Autoimmune Disease Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 148: Latin American Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Indication for the Period 2018-2025

TABLE 149: Autoimmune Disease Therapeutics Historic Market Analysis in Latin America in US$ Million by Indication: 2009-2017

TABLE 150: Latin American Autoimmune Disease Therapeutics Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 151: Argentinean Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 152: Autoimmune Disease Therapeutics Market in Argentina in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 153: Argentinean Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 154: Argentinean Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018-2025

TABLE 155: Autoimmune Disease Therapeutics Market in Argentina in US$ Million by Indication: A Historic Review for the Period 2009-2017

TABLE 156: Argentinean Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

BRAZIL

TABLE 157: Autoimmune Disease Therapeutics Market in Brazil by Drug Class: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 158: Brazilian Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Drug Class: 2009-2017

TABLE 159: Brazilian Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 160: Autoimmune Disease Therapeutics Market in Brazil by Indication: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 161: Brazilian Autoimmune Disease Therapeutics Historic Market Scenario in US$ Million by Indication: 2009-2017

TABLE 162: Brazilian Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025

MEXICO

TABLE 163: Autoimmune Disease Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 164: Mexican Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 165: Mexican Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 166: Autoimmune Disease Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025

TABLE 167: Mexican Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017

TABLE 168: Mexican Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 169: Rest of Latin America Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 170: Autoimmune Disease Therapeutics Market in Rest of Latin America by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 171: Rest of Latin America Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 172: Rest of Latin America Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Indication: 2018 to 2025

TABLE 173: Autoimmune Disease Therapeutics Market in Rest of Latin America by Indication: A Historic Review in US$ Million for 2009-2017

TABLE 174: Rest of Latin America Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 175: The Middle East Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 176: Autoimmune Disease Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 177: The Middle East Autoimmune Disease Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 178: The Middle East Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018 to 2025

TABLE 179: The Middle East Autoimmune Disease Therapeutics Historic Market by Drug Class in US$ Million: 2009-2017

TABLE 180: Autoimmune Disease Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025

TABLE 181: The Middle East Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018 to 2025

TABLE 182: The Middle East Autoimmune Disease Therapeutics Historic Market by Indication in US$ Million: 2009-2017

TABLE 183: Autoimmune Disease Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Indication for 2009, 2019, and 2025

IRAN

TABLE 184: Iranian Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Drug Class for the Period 2018-2025

TABLE 185: Autoimmune Disease Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Drug Class for the Period 2009-2017

TABLE 186: Iranian Autoimmune Disease Therapeutics Market Share Analysis by Drug Class: 2009 VS 2019 VS 2025

TABLE 187: Iranian Market for Autoimmune Disease Therapeutics: Annual Sales Estimates and Projections in US$ Million by Indication for the Period 2018-2025

TABLE 188: Autoimmune Disease Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Indication for the Period 2009-2017

TABLE 189: Iranian Autoimmune Disease Therapeutics Market Share Analysis by Indication: 2009 VS 2019 VS 2025

ISRAEL

TABLE 190: Israeli Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Drug Class: 2018-2025

TABLE 191: Autoimmune Disease Therapeutics Market in Israel in US$ Million by Drug Class: A Historic Review for the Period 2009-2017

TABLE 192: Israeli Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 193: Israeli Autoimmune Disease Therapeutics Market Estimates and Forecasts in US$ Million by Indication: 2018-2025

TABLE 194: Autoimmune Disease Therapeutics Market in Israel in US$ Million by Indication: A Historic Review for the Period 2009-2017

TABLE 195: Israeli Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 196: Saudi Arabian Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Drug Class for the Period 2018-2025

TABLE 197: Autoimmune Disease Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Drug Class: 2009-2017

TABLE 198: Saudi Arabian Autoimmune Disease Therapeutics Market by Drug Class: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 199: Saudi Arabian Autoimmune Disease Therapeutics Market Growth Prospects in US$ Million by Indication for the Period 2018-2025

TABLE 200: Autoimmune Disease Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Indication: 2009-2017

TABLE 201: Saudi Arabian Autoimmune Disease Therapeutics Market by Indication: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 202: Autoimmune Disease Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 203: United Arab Emirates Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 204: Autoimmune Disease Therapeutics Market Share Distribution in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025

TABLE 205: Autoimmune Disease Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025

TABLE 206: United Arab Emirates Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017

TABLE 207: Autoimmune Disease Therapeutics Market Share Distribution in United Arab Emirates by Indication: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 208: Autoimmune Disease Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Drug Class for the Period 2018-2025

TABLE 209: Rest of Middle East Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Drug Class: 2009-2017

TABLE 210: Rest of Middle East Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 211: Autoimmune Disease Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Indication for the Period 2018-2025

TABLE 212: Rest of Middle East Autoimmune Disease Therapeutics Historic Market Analysis in US$ Million by Indication: 2009-2017

TABLE 213: Rest of Middle East Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

AFRICA

TABLE 214: African Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Drug Class: 2018 to 2025

TABLE 215: Autoimmune Disease Therapeutics Market in Africa by Drug Class: A Historic Review in US$ Million for 2009-2017

TABLE 216: African Autoimmune Disease Therapeutics Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025

TABLE 217: African Autoimmune Disease Therapeutics Market Estimates and Projections in US$ Million by Indication: 2018 to 2025

TABLE 218: Autoimmune Disease Therapeutics Market in Africa by Indication: A Historic Review in US$ Million for 2009-2017

TABLE 219: African Autoimmune Disease Therapeutics Market Share Breakdown by Indication: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBOTT LABORATORIES

ABBVIE

AMGEN

ASTRAZENECA PLC

BRISTOL-MYERS SQUIBB COMPANY

F. HOFFMANN-LA ROCHE AG

JOHNSON & JOHNSON

NOVARTIS INTERNATIONAL AG

PFIZER

UCB SA

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • Abbvie
  • Amgen
  • Astrazeneca Plc
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Novartis International Ag
  • Pfizer
  • Ucb Sa
Note: Product cover images may vary from those shown
Adroll
adroll